Nathalie Maubon,
CEO/CSO
With 15 years of experience of pharmaceutical research in public research, the pharmaceutical industry and biotechnology companies, Nathalie Maubon is a specialist in the development and automation of robust models for high-throughput screening (HCS, HTS, ADMET). Nathalie is now CEO and CSO of HCS Pharma, a company she created to combine the expertise of scientific researchers about disease mechanisms, with researchers from industry who specialize in automation and high throughput screening.
|
|
|
